Literature DB >> 21914247

Anterior tongue reduction surgery for paediatric macroglossia.

H Chau1, M Soma, S Massey, R Hewitt, B Hartley.   

Abstract

OBJECTIVE: Anterior tongue reduction is indicated when macroglossia causes problems with oral hygiene, airway compromise, deglutition, articulation or orthognathic complications. Causes of macroglossia include hypothyroidism, mucopolysaccharide and lipid storage disease, lymphangioma, haemangioma, neurofibroma, and muscular macroglossia. This paper presents an 11-year experience of anterior tongue reduction at Great Ormond Street Hospital.
METHOD: Retrospective study of patient medical records identified from the hospital ENT database. Anterior wedge resection was the preferred technique.
RESULTS: Anterior tongue reduction was performed on 18 patients, due to cystic hygroma with tongue involvement (nine patients), Beckwith-Wiedemann syndrome (eight) and Down's syndrome (one). Anterior wedge resection was preferred, using electrocautery in the majority, except for four cases involving CO2 laser. All but one patient had a good surgical outcome (i.e. tongue in mouth at rest). One patient subsequently required multiple laser procedures for recurrent macroglossia.
CONCLUSION: Anterior tongue reduction can be a safe procedure, with limited post-operative morbidity, consistently resulting in good surgical outcomes and improvement in macroglossia symptoms. Speech development does not appear to be adversely affected.

Entities:  

Mesh:

Year:  2011        PMID: 21914247     DOI: 10.1017/S0022215111002015

Source DB:  PubMed          Journal:  J Laryngol Otol        ISSN: 0022-2151            Impact factor:   1.469


  2 in total

1.  Internal Kinematics of the Volume-Reduced Tongue: A Longitudinal Microsonometric Study.

Authors:  Jie Chen; Volodymyr Shcherbatyy; Zi-Jun Liu
Journal:  Anat Rec (Hoboken)       Date:  2015-11-14       Impact factor: 2.064

2.  Oral manifestation and dental treatment of pediatric patient with beta-mannosidosis: A case report.

Authors:  Mohammad A Alshoraim; Dania E Al Agili
Journal:  SAGE Open Med Case Rep       Date:  2021-12-15
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.